Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series.
Schwartz-Jampel syndrome is a rare autosomal recessive disorder characterized by myotonia and skeletal dysplasia. Botulinum toxin A is emerging as a therapeutic option for patients with this syndrome. This study describes the use of botulinum toxin A in 4 children with Schwartz-Jampel syndrome. The response to this therapeutic modality was limited and variable.
Aburahma
Samah Khalil
SK
Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. samahk@just.edu.jo
Al-Khateeb
Taiseer
T
Alrefai
Ali
A
Amarin
Zouhair
Z
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010009:Osteochondrodysplasias / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A